Senate to Consider Comparative Effectiveness Institute Bill | GenomeWeb

NEW YORK (GenomeWeb News) – A bill to create a national institute to study comparative clinical effectiveness of medical treatments and diagnostics — including the use of molecular medicine and genetics to inform those studies — was introduced in the US Senate this week by Senators Max Baucus (D – Mont.) and Kent Conrad (D – ND).

The bill calls for the creation of the Patient-Centered Outcomes Research Institute, which would be a non-profit entity run by "a multi-stakeholder, public-private sector board of governors," Baucus said in a floor statement to the Senate on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.